会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHOD OF TREATMENT OR PREVENTION OF AGE-RELATED MACULAR DEGENERATION
    • 治疗或预防老年相关性变性的方法
    • WO2007029008A2
    • 2007-03-15
    • PCT/GB2006003331
    • 2006-09-08
    • DSM IP ASSETS BVWRIGHT SIMON MARKGORALCZYC REGINADE SAIZIEU ANTOINESCHALCH WOLGFANGBENDIK IGOR
    • GORALCZYC REGINADE SAIZIEU ANTOINESCHALCH WOLGFANGBENDIK IGOR
    • A61K33/34A61K31/047A61K31/355A61K31/375A61K33/30A61K2300/00
    • A method of treatment and/or prevention of age-related macular degeneration (AMD) wherein, in a first step, the need for treatment or susceptibility to AMD is determined for an individual and, in a second step, a medication comprising lutein and/or zeaxanthin and/or certain antioxidants (or a mixture thereof) is tailored to that individual. The invention also provides a method of determining a substance to be administered to an individual, which individual may be susceptible of having age-related macular degeneration (or an age-related macular degeneration-related disorder) comprising: a) determining the susceptibility of the individual to age-related macular degeneration (usually genetically, by detection of an SNP); and b) on the basis of the determination in a), identifying a substance capable of preventing or treating age-related macular degeneration in that individual. The method may additionally comprise providing (such as administering or communicating) the substance (or its identity) to the individual.
    • 一种治疗和/或预防年龄相关性黄斑变性(AMD)的方法,其中在第一步骤中,对个体确定对AMD的治疗或易感性的需要,并且在第二步骤中,包含叶黄素和/ 或玉米黄质和/或某些抗氧化剂(或其混合物)适合该个体。 本发明还提供了确定待给予个体的物质的方法,该个体可能易患有年龄相关性黄斑变性(或年龄相关性黄斑变性相关病症),其包括:a)确定 个体对年龄相关性黄斑变性(通常在遗传上,通过检测SNP); 和b)基于a)中确定的物质,鉴定能够预防或治疗该个体年龄相关性黄斑变性的物质。 该方法可以另外包括向个体提供(例如管理或通信)物质(或其身份)。